{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Script to\n",
    "1. get dosage range overlap across datasets, dosage range in GDSC andother metdata for each drug for analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "__author__ = 'Aanchal'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import FUNCTIONS as f\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "impClsOnly=0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "plotting_df=pd.DataFrame();"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### fetch dosage overlap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "dr_metadata= f.get_common_drugs_metadata(\"../data/metadata_2019_08_15_aanchal.xlsx\", \"common_drugs\")\n",
    "\n",
    "plotting_df['Standard drug name']=dr_metadata['Standard drug name']\n",
    "plotting_df['dosage range overlap']=dr_metadata['dosage range overlap']\n",
    "plotting_df['GDSC dosage length']=dr_metadata['GDSC dosage length']\n",
    "plotting_df['GDSC min dosage']=dr_metadata['GDSC min dosage']\n",
    "plotting_df['GDSC max dosage']=dr_metadata['GDSC max dosage']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## INITIALIZATION "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "FeatureMatrix=pd.read_csv('../data_processed/FittedCurvesCommonPairs_features/Feature_Matrix_FLatPerDrugFitting_15features.csv') # #Normalized_outliersCapped\n",
    "\n",
    "FeatureMatrix=FeatureMatrix[['Standard cell line name','Standard drug name','IS','mae_fitness','ic50_mode','m_mode','log2(max_dosage_bothDatasets)']]\n",
    "\n",
    "pair_dosages=pd.read_csv('../data_processed/GDSC_pair_dosage_range.csv').sort_values('Standard cell line name')\n",
    "FeatureMatrix=pd.merge(FeatureMatrix, pair_dosages,on=['Standard cell line name','Standard drug name']) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "mu, sigma, Amp for 2 modes=> [  3.13451253   2.10144539 208.54370961  10.01568898   1.87162126\n",
      " 129.59934495]\n",
      "Th=mu+std of 1st gaussian pofile: 7.065115744557399\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from pylab import hist\n",
    "'''hist(FeatureMatrix['ic50_mode'] , bins=100) #FeatureMatrix['IS'] #FeatureMatrix['m_mode']\n",
    "plt.title('Distribution of ic50_mode for all pairs')\n",
    "plt.xlabel('value of ic50_mode')\n",
    "plt.ylabel('# pairs')\n",
    "plt.show()'''\n",
    "#temp=df[df['sensitivity_calls_ic50_label']==1]\n",
    "#hist(temp['ic50_mode'] , bins=100)\n",
    "\n",
    "[mus,stds, params,xh,yh] = f.fit_mixtureOfGaussians(FeatureMatrix[['ic50_mode']],[2.5,5,130,  10,5,60])\n",
    "\n",
    "#st_ind=np.where(params==max(mus))\n",
    "th=mus[0]+2*stds[0] #not using anymore since both the dsitributions mus tbe used to separate the 2 modes..not just 1\n",
    "\n",
    "th= f.split_bimodal(xh, f.bimodal(xh,params[0],params[1],params[2],params[3],params[4],params[5])  ,mus)[0]\n",
    "\n",
    "plt.axvline(x=mus[0], color='g', linestyle='--', label='mu1')\n",
    "plt.axvline(x=mus[1], color='g', linestyle='--', label='mu2')\n",
    "plt.axvline(x=th ,color='k', linestyle='--', label='threshold')\n",
    "plt.xlabel('IC50_mode')\n",
    "plt.ylabel('# Pairs')\n",
    "plt.title('chosen threshold to separate resistant pairs='+str( th.round(2)) )\n",
    "print(\"Th=mu+std of 1st gaussian pofile:\", th)\n",
    "plt.savefig('../figures/InconsistencyFactorAnalysis/IC50_mode_distibution.svg')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "FeatureMatrix['Sensitivity_basedOnIC50th'] = np.where(FeatureMatrix['ic50_mode']> th, 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7.065115744557399"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "th"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "#filter Cls which havent been tested for all drugs\n",
    "if(impClsOnly==1):\n",
    "    all_cls=FeatureMatrix.groupby(FeatureMatrix['Standard cell line name']).count()[['Standard drug name']]\n",
    "    FeatureMatrix_impcls=FeatureMatrix.loc[FeatureMatrix['Standard cell line name'].isin(all_cls[all_cls['Standard drug name']==15].index)]\n",
    "else:\n",
    "    FeatureMatrix_impcls=FeatureMatrix\n",
    "\n",
    "#filter resistant Cls\n",
    "FeatureMatrix_sensitivePairs=FeatureMatrix_impcls[FeatureMatrix_impcls['ic50_mode']<=th]\n",
    "\n",
    "#get mean IS\n",
    "drug_wise_mean=FeatureMatrix_sensitivePairs.groupby('Standard drug name')['Standard drug name','IS'].mean() #takes med of all cols\n",
    "drug_wise_mean.rename(columns={'IS': 'mean IS'}, inplace=True)\n",
    "\n",
    "\n",
    "#get median IS\n",
    "drug_wise_median=FeatureMatrix_sensitivePairs.groupby('Standard drug name')['Standard drug name','IS','ic50_mode'].median() #takes med of all cols\n",
    "drug_wise_median.rename(columns={'IS': 'median IS', 'ic50_mode': 'median ic50_mode'}, inplace=True)\n",
    "\n",
    "AAA_matrix=FeatureMatrix_sensitivePairs\n",
    "AAA_matrix=AAA_matrix.set_index('Standard drug name')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2111"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(FeatureMatrix_sensitivePairs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df=FeatureMatrix_sensitivePairs.groupby(FeatureMatrix_sensitivePairs['Standard drug name']).agg({'Sensitivity_basedOnIC50nMaxDosage': [sum, \"count\"]})#['Standard drug name','Sensitivity'].describe()#.count()#.size()#.unstack()\n",
    "#df['fraction_resistant_CLs']=df['Sensitivity_basedOnIC50nMaxDosage']['sum']/df['Sensitivity_basedOnIC50nMaxDosage']['count']#['Sensitivity'][['sum']]#df['%age resistant CLs']=df['Standard drug name']\n",
    "#Sensitivity_basedOnIC50th shud be used to find fraction of resistant cls\n",
    "\n",
    "plotting_df['mean IS']=drug_wise_mean['mean IS']\n",
    "plotting_df['median IS']=drug_wise_median['median IS']\n",
    "plotting_df['median ic50_mode']=drug_wise_median['median ic50_mode']\n",
    "plotting_df['#total CLs']=FeatureMatrix.groupby('Standard drug name').count()['Standard cell line name']\n",
    "plotting_df['#CLs tested for all']=FeatureMatrix_impcls.groupby('Standard drug name').count()['Standard cell line name']\n",
    "plotting_df['#sensitive CLs']=FeatureMatrix_sensitivePairs.groupby('Standard drug name').count()['Standard cell line name']\n",
    "\n",
    "plotting_df['Target Pathway']=dr_metadata['Target Pathway']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "###plotting_df=AAA_matrix.merge(plotting_df,left_index=True, right_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "if(impClsOnly==1):\n",
    "    plotting_df.to_csv('../data_processed/InconsistencyFactorAnalysis/drug_analysis_onlySensitiveCLs_testedFor15drugs.csv')\n",
    "else:\n",
    "    plotting_df.to_csv('../data_processed/InconsistencyFactorAnalysis/drug_analysis_onlySensitiveCLs.csv') "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Standard drug name</th>\n",
       "      <th>dosage range overlap</th>\n",
       "      <th>GDSC dosage length</th>\n",
       "      <th>GDSC min dosage</th>\n",
       "      <th>GDSC max dosage</th>\n",
       "      <th>mean IS</th>\n",
       "      <th>median IS</th>\n",
       "      <th>median ic50_mode</th>\n",
       "      <th>#total CLs</th>\n",
       "      <th>#CLs tested for all</th>\n",
       "      <th>#sensitive CLs</th>\n",
       "      <th>Target Pathway</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Crizotinib</th>\n",
       "      <td>Crizotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.107829</td>\n",
       "      <td>0.103645</td>\n",
       "      <td>2.957263</td>\n",
       "      <td>114</td>\n",
       "      <td>114</td>\n",
       "      <td>94</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Erlotinib</th>\n",
       "      <td>Erlotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.119941</td>\n",
       "      <td>0.102278</td>\n",
       "      <td>3.701837</td>\n",
       "      <td>100</td>\n",
       "      <td>100</td>\n",
       "      <td>53</td>\n",
       "      <td>EGFR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Lapatinib</th>\n",
       "      <td>Lapatinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.115872</td>\n",
       "      <td>0.102910</td>\n",
       "      <td>3.235758</td>\n",
       "      <td>107</td>\n",
       "      <td>107</td>\n",
       "      <td>75</td>\n",
       "      <td>EGFR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NVP-TAE684</th>\n",
       "      <td>NVP-TAE684</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.172550</td>\n",
       "      <td>0.155214</td>\n",
       "      <td>1.250724</td>\n",
       "      <td>114</td>\n",
       "      <td>114</td>\n",
       "      <td>101</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nilotinib</th>\n",
       "      <td>Nilotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.106223</td>\n",
       "      <td>0.100904</td>\n",
       "      <td>3.334104</td>\n",
       "      <td>261</td>\n",
       "      <td>261</td>\n",
       "      <td>193</td>\n",
       "      <td>ABL signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nutlin-3a</th>\n",
       "      <td>Nutlin-3a</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-5.000000</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>0.121485</td>\n",
       "      <td>0.117368</td>\n",
       "      <td>3.951566</td>\n",
       "      <td>338</td>\n",
       "      <td>338</td>\n",
       "      <td>114</td>\n",
       "      <td>p53 pathway</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PD0325901</th>\n",
       "      <td>PD0325901</td>\n",
       "      <td>6.643856</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-10.000000</td>\n",
       "      <td>-2.000000</td>\n",
       "      <td>0.187796</td>\n",
       "      <td>0.178875</td>\n",
       "      <td>1.349537</td>\n",
       "      <td>334</td>\n",
       "      <td>334</td>\n",
       "      <td>260</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PHA-665752</th>\n",
       "      <td>PHA-665752</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.098676</td>\n",
       "      <td>0.084305</td>\n",
       "      <td>3.475073</td>\n",
       "      <td>114</td>\n",
       "      <td>114</td>\n",
       "      <td>82</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PLX-4720</th>\n",
       "      <td>PLX-4720</td>\n",
       "      <td>7.678072</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-4.678072</td>\n",
       "      <td>3.321928</td>\n",
       "      <td>0.102988</td>\n",
       "      <td>0.088872</td>\n",
       "      <td>4.205163</td>\n",
       "      <td>330</td>\n",
       "      <td>330</td>\n",
       "      <td>138</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Paclitaxel</th>\n",
       "      <td>Paclitaxel</td>\n",
       "      <td>5.356144</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-11.287712</td>\n",
       "      <td>-3.287712</td>\n",
       "      <td>0.212052</td>\n",
       "      <td>0.202824</td>\n",
       "      <td>-5.228258</td>\n",
       "      <td>110</td>\n",
       "      <td>110</td>\n",
       "      <td>110</td>\n",
       "      <td>Mitosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Palbociclib</th>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.174411</td>\n",
       "      <td>0.165468</td>\n",
       "      <td>3.681539</td>\n",
       "      <td>278</td>\n",
       "      <td>278</td>\n",
       "      <td>207</td>\n",
       "      <td>Cell cycle</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Saracatinib</th>\n",
       "      <td>Saracatinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.125424</td>\n",
       "      <td>0.116847</td>\n",
       "      <td>3.131690</td>\n",
       "      <td>114</td>\n",
       "      <td>114</td>\n",
       "      <td>75</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Selumetinib</th>\n",
       "      <td>Selumetinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.172184</td>\n",
       "      <td>0.161900</td>\n",
       "      <td>3.540782</td>\n",
       "      <td>322</td>\n",
       "      <td>322</td>\n",
       "      <td>204</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sorafenib</th>\n",
       "      <td>Sorafenib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.118941</td>\n",
       "      <td>0.118774</td>\n",
       "      <td>2.827652</td>\n",
       "      <td>110</td>\n",
       "      <td>110</td>\n",
       "      <td>68</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tanespimycin</th>\n",
       "      <td>Tanespimycin</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-8.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.216004</td>\n",
       "      <td>0.204158</td>\n",
       "      <td>-1.469640</td>\n",
       "      <td>337</td>\n",
       "      <td>337</td>\n",
       "      <td>337</td>\n",
       "      <td>Protein stability and degradation</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             Standard drug name  dosage range overlap  GDSC dosage length  \\\n",
       "name                                                                        \n",
       "Crizotinib           Crizotinib              8.000000                 8.0   \n",
       "Erlotinib             Erlotinib              8.000000                 8.0   \n",
       "Lapatinib             Lapatinib              8.000000                 8.0   \n",
       "NVP-TAE684           NVP-TAE684              8.000000                 8.0   \n",
       "Nilotinib             Nilotinib              8.000000                 8.0   \n",
       "Nutlin-3a             Nutlin-3a              8.000000                 8.0   \n",
       "PD0325901             PD0325901              6.643856                 8.0   \n",
       "PHA-665752           PHA-665752              8.000000                 8.0   \n",
       "PLX-4720               PLX-4720              7.678072                 8.0   \n",
       "Paclitaxel           Paclitaxel              5.356144                 8.0   \n",
       "Palbociclib         Palbociclib              8.000000                 8.0   \n",
       "Saracatinib         Saracatinib              8.000000                 8.0   \n",
       "Selumetinib         Selumetinib              8.000000                 8.0   \n",
       "Sorafenib             Sorafenib              8.000000                 8.0   \n",
       "Tanespimycin       Tanespimycin              8.000000                 8.0   \n",
       "\n",
       "              GDSC min dosage  GDSC max dosage   mean IS  median IS  \\\n",
       "name                                                                  \n",
       "Crizotinib          -7.000000         1.000000  0.107829   0.103645   \n",
       "Erlotinib           -7.000000         1.000000  0.119941   0.102278   \n",
       "Lapatinib           -7.000000         1.000000  0.115872   0.102910   \n",
       "NVP-TAE684          -7.000000         1.000000  0.172550   0.155214   \n",
       "Nilotinib           -7.000000         1.000000  0.106223   0.100904   \n",
       "Nutlin-3a           -5.000000         3.000000  0.121485   0.117368   \n",
       "PD0325901          -10.000000        -2.000000  0.187796   0.178875   \n",
       "PHA-665752          -7.000000         1.000000  0.098676   0.084305   \n",
       "PLX-4720            -4.678072         3.321928  0.102988   0.088872   \n",
       "Paclitaxel         -11.287712        -3.287712  0.212052   0.202824   \n",
       "Palbociclib         -6.000000         2.000000  0.174411   0.165468   \n",
       "Saracatinib         -7.000000         1.000000  0.125424   0.116847   \n",
       "Selumetinib         -6.000000         2.000000  0.172184   0.161900   \n",
       "Sorafenib           -6.000000         2.000000  0.118941   0.118774   \n",
       "Tanespimycin        -8.000000         0.000000  0.216004   0.204158   \n",
       "\n",
       "              median ic50_mode  #total CLs  #CLs tested for all  \\\n",
       "name                                                              \n",
       "Crizotinib            2.957263         114                  114   \n",
       "Erlotinib             3.701837         100                  100   \n",
       "Lapatinib             3.235758         107                  107   \n",
       "NVP-TAE684            1.250724         114                  114   \n",
       "Nilotinib             3.334104         261                  261   \n",
       "Nutlin-3a             3.951566         338                  338   \n",
       "PD0325901             1.349537         334                  334   \n",
       "PHA-665752            3.475073         114                  114   \n",
       "PLX-4720              4.205163         330                  330   \n",
       "Paclitaxel           -5.228258         110                  110   \n",
       "Palbociclib           3.681539         278                  278   \n",
       "Saracatinib           3.131690         114                  114   \n",
       "Selumetinib           3.540782         322                  322   \n",
       "Sorafenib             2.827652         110                  110   \n",
       "Tanespimycin         -1.469640         337                  337   \n",
       "\n",
       "              #sensitive CLs                     Target Pathway  \n",
       "name                                                             \n",
       "Crizotinib                94                      RTK signaling  \n",
       "Erlotinib                 53                     EGFR signaling  \n",
       "Lapatinib                 75                     EGFR signaling  \n",
       "NVP-TAE684               101                      RTK signaling  \n",
       "Nilotinib                193                      ABL signaling  \n",
       "Nutlin-3a                114                        p53 pathway  \n",
       "PD0325901                260                 ERK MAPK signaling  \n",
       "PHA-665752                82                      RTK signaling  \n",
       "PLX-4720                 138                 ERK MAPK signaling  \n",
       "Paclitaxel               110                            Mitosis  \n",
       "Palbociclib              207                         Cell cycle  \n",
       "Saracatinib               75                      RTK signaling  \n",
       "Selumetinib              204                 ERK MAPK signaling  \n",
       "Sorafenib                 68                      RTK signaling  \n",
       "Tanespimycin             337  Protein stability and degradation  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "plotting_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
